Immunohistochemical tissue microarray analysis of NURR1 demonstrated that cancer cells in high Gleason-score lesions in hormone-naïve prostate cancer expressed higher nuclear immunoreactivity than that in glandular epithelial cells in non-cancerous tissues, which expressed either weak or negative immunoreactivity (Fig. 1C). The gene discussed is NR4A2; the disease is cancer.